Curiel DT - Search Results

1

Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.

Sarkar D, Lebedeva IV, Su ZZ, Park ES, Chatman L, Vozhilla N, Dent P, Curiel DT, Fisher PB. Sarkar D, et al. Among authors: curiel dt. Cancer Res. 2007 Jun 1;67(11):5434-42. doi: 10.1158/0008-5472.CAN-07-0195. Cancer Res. 2007. PMID: 17545625

2

Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector.

Rogers BE, Curiel DT, Mayo MS, Laffoon KK, Bright SJ, Buchsbaum DJ. Rogers BE, et al. Among authors: curiel dt. Cancer. 1997 Dec 15;80(12 Suppl):2419-24. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2419::aid-cncr13>3.3.co;2-5. Cancer. 1997. PMID: 9406692

3

Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects.

Wang-Johanning F, Gillespie GY, Grim J, Rancourt C, Alvarez RD, Siegal GP, Curiel DT. Wang-Johanning F, et al. Among authors: curiel dt. Cancer Res. 1998 May 1;58(9):1893-900. Cancer Res. 1998. PMID: 9581830

4

Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer.

Rancourt C, Rogers BE, Sosnowski BA, Wang M, Piché A, Pierce GF, Alvarez RD, Siegal GP, Douglas JT, Curiel DT. Rancourt C, et al. Among authors: curiel dt. Clin Cancer Res. 1998 Oct;4(10):2455-61. Clin Cancer Res. 1998. PMID: 9796978

5

Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.

Rosenfeld ME, Feng M, Michael SI, Siegal GP, Alvarez RD, Curiel DT. Rosenfeld ME, et al. Among authors: curiel dt. Clin Cancer Res. 1995 Dec;1(12):1571-80. Clin Cancer Res. 1995. PMID: 9815958

6

Adeno-associated virus for cancer gene therapy.

Ponnazhagan S, Curiel DT, Shaw DR, Alvarez RD, Siegal GP. Ponnazhagan S, et al. Among authors: curiel dt. Cancer Res. 2001 Sep 1;61(17):6313-21. Cancer Res. 2001. PMID: 11522617 Review. No abstract available.

7

Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule.

Hemminki A, Dmitriev I, Liu B, Desmond RA, Alemany R, Curiel DT. Hemminki A, et al. Among authors: curiel dt. Cancer Res. 2001 Sep 1;61(17):6377-81. Cancer Res. 2001. PMID: 11522629

8

A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.

Adachi Y, Reynolds PN, Yamamoto M, Wang M, Takayama K, Matsubara S, Muramatsu T, Curiel DT. Adachi Y, et al. Among authors: curiel dt. Cancer Res. 2001 Nov 1;61(21):7882-8. Cancer Res. 2001. PMID: 11691808

9

Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.

Haviv YS, Blackwell JL, Kanerva A, Nagi P, Krasnykh V, Dmitriev I, Wang M, Naito S, Lei X, Hemminki A, Carey D, Curiel DT. Haviv YS, et al. Among authors: curiel dt. Cancer Res. 2002 Aug 1;62(15):4273-81. Cancer Res. 2002. PMID: 12154029

10

Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.

Nettelbeck DM, Rivera AA, Balagué C, Alemany R, Curiel DT. Nettelbeck DM, et al. Among authors: curiel dt. Cancer Res. 2002 Aug 15;62(16):4663-70. Cancer Res. 2002. PMID: 12183423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters